These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
271 related items for PubMed ID: 10232601
1. Regulation of transforming growth factor beta1 by nitric oxide. Vodovotz Y, Chesler L, Chong H, Kim SJ, Simpson JT, DeGraff W, Cox GW, Roberts AB, Wink DA, Barcellos-Hoff MH. Cancer Res; 1999 May 01; 59(9):2142-9. PubMed ID: 10232601 [Abstract] [Full Text] [Related]
2. TGF-beta1 suppresses IFN-gamma-induced NO production in macrophages by suppressing STAT1 activation and accelerating iNOS protein degradation. Takaki H, Minoda Y, Koga K, Takaesu G, Yoshimura A, Kobayashi T. Genes Cells; 2006 Aug 01; 11(8):871-82. PubMed ID: 16866871 [Abstract] [Full Text] [Related]
3. Bryostatin-1 and IFN-gamma synergize for the expression of the inducible nitric oxide synthase gene and for nitric oxide production in murine macrophages. Taylor LS, Cox GW, Melillo G, Bosco MC, Espinoza-Delgado I. Cancer Res; 1997 Jun 15; 57(12):2468-73. PubMed ID: 9192827 [Abstract] [Full Text] [Related]
5. Autocrine/paracrine IFN-alphabeta mediates the lipopolysaccharide-induced activation of transcription factor Stat1alpha in mouse macrophages: pivotal role of Stat1alpha in induction of the inducible nitric oxide synthase gene. Gao JJ, Filla MB, Fultz MJ, Vogel SN, Russell SW, Murphy WJ. J Immunol; 1998 Nov 01; 161(9):4803-10. PubMed ID: 9794412 [Abstract] [Full Text] [Related]
6. TGF-beta1 potentiates astrocytic nitric oxide production by expanding the population of astrocytes that express NOS-2. Hamby ME, Hewett JA, Hewett SJ. Glia; 2006 Nov 01; 54(6):566-77. PubMed ID: 16921522 [Abstract] [Full Text] [Related]
9. Suppression of macrophage function in AK-5 tumor transplanted animals: role of TGF-beta1. Mitra R, Khar A. Immunol Lett; 2004 Feb 15; 91(2-3):189-95. PubMed ID: 15019289 [Abstract] [Full Text] [Related]
10. The microbicidal activity of interferon-gamma-treated macrophages against Trypanosoma cruzi involves an L-arginine-dependent, nitrogen oxide-mediated mechanism inhibitable by interleukin-10 and transforming growth factor-beta. Gazzinelli RT, Oswald IP, Hieny S, James SL, Sher A. Eur J Immunol; 1992 Oct 15; 22(10):2501-6. PubMed ID: 1396957 [Abstract] [Full Text] [Related]
11. Down-regulation of transforming growth factor-beta gene expression by antisense oligodeoxynucleotides increases recombinant interferon-gamma-induced nitric oxide synthesis in murine peritoneal macrophages. Jun CD, Choi BM, Kim SU, Lee SY, Kim HM, Chung HT. Immunology; 1995 May 15; 85(1):114-9. PubMed ID: 7635512 [Abstract] [Full Text] [Related]
12. Transforming growth factor-beta 1 primes macrophages for enhanced expression of the nitric oxide synthase gene for nitric oxide-dependent cytotoxicity against Entamoeba histolytica. Lin JY, Seguin R, Keller K, Chadee K. Immunology; 1995 Jul 15; 85(3):400-7. PubMed ID: 7558128 [Abstract] [Full Text] [Related]
13. Tumor-infiltrating macrophages are involved in suppressing growth and metastasis of human prostate cancer cells by INF-beta gene therapy in nude mice. Zhang F, Lu W, Dong Z. Clin Cancer Res; 2002 Sep 15; 8(9):2942-51. PubMed ID: 12231540 [Abstract] [Full Text] [Related]
14. Regulation of TGF-beta1 gene transcription in human prostate cancer cells by nitric oxide. Wang D, Lu S, Dong Z. Prostate; 2007 Dec 01; 67(16):1825-33. PubMed ID: 17941092 [Abstract] [Full Text] [Related]
15. Nitric oxide synthase is induced in tumor promoter-sensitive, but not tumor promoter-resistant, JB6 mouse epidermal cells cocultured with interferon-gamma-stimulated RAW 264.7 cells: the role of tumor necrosis factor-alpha. Murakami A, Kawabata K, Koshiba T, Gao G, Nakamura Y, Koshimizu K, Ohigashi H. Cancer Res; 2000 Nov 15; 60(22):6326-31. PubMed ID: 11103793 [Abstract] [Full Text] [Related]
16. The first stage of transforming growth factor beta1 activation is release of the large latent complex from the extracellular matrix of growth plate chondrocytes by matrix vesicle stromelysin-1 (MMP-3). Maeda S, Dean DD, Gomez R, Schwartz Z, Boyan BD. Calcif Tissue Int; 2002 Jan 15; 70(1):54-65. PubMed ID: 11907708 [Abstract] [Full Text] [Related]
17. Intact nitric oxide synthase II gene is required for interferon-beta-mediated suppression of growth and metastasis of pancreatic adenocarcinoma. Wang B, Xiong Q, Shi Q, Le X, Abbruzzese JL, Xie K. Cancer Res; 2001 Jan 01; 61(1):71-5. PubMed ID: 11196200 [Abstract] [Full Text] [Related]
18. Isoform-specific activation of latent transforming growth factor beta (LTGF-beta) by reactive oxygen species. Jobling MF, Mott JD, Finnegan MT, Jurukovski V, Erickson AC, Walian PJ, Taylor SE, Ledbetter S, Lawrence CM, Rifkin DB, Barcellos-Hoff MH. Radiat Res; 2006 Dec 01; 166(6):839-48. PubMed ID: 17149983 [Abstract] [Full Text] [Related]
19. Defective processing of the transforming growth factor-beta1 in azoxymethane-induced mouse colon tumors. Guda K, Claffey KP, Dong M, Nambiar PR, Rosenberg DW. Mol Carcinog; 2003 May 01; 37(1):51-9. PubMed ID: 12720300 [Abstract] [Full Text] [Related]
20. Toxoplasma gondii exposes phosphatidylserine inducing a TGF-beta1 autocrine effect orchestrating macrophage evasion. Seabra SH, de Souza W, Damatta RA. Biochem Biophys Res Commun; 2004 Nov 12; 324(2):744-52. PubMed ID: 15474490 [Abstract] [Full Text] [Related] Page: [Next] [New Search]